文献速递前列腺癌

前列腺周围脂肪与主动监测中局限性前列腺癌分级进展的关联

The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance.
PubMed 文献 · J Urol · 2020-07-27

本研究纳入175例接受主动监测的局限性前列腺癌患者,利用前列腺MRI测量皮下、线性前列腺周围及体积法前列腺周围脂肪,并按前列腺大小标准化后分析其与Gleason分级组进展的关系。中位随访42个月,50例(28.6%)出现进展;体积法及线性前列腺周围脂肪最高三分位与无进展生存期变差相关,而皮下脂肪无关联。

要点

  • 前列腺周围脂肪体积(经前列腺大小标准化)增加与主动监测中分级进展风险升高相关。
  • 体积法前列腺周围脂肪最高三分位较低三分位进展风险HR 2.63(95%CI 1.23-5.60,p=0.01)。
  • 线性前列腺周围脂肪最高三分位较低三分位进展风险HR 2.30(95%CI 1.01-5.22,p=0.05),皮下脂肪无关联。

核心结论

  • 经前列腺大小标准化的前列腺周围脂肪体积增加可能与主动监测患者无进展生存期缩短相关。

研究设计与样本

  • 前瞻性主动监测试验中入组至少6个月且入组2年内有MRI的患者,共175例。
  • 中位随访42个月(IQR 18-60),平均年龄62.5岁(SD 7.4),平均PSA 5.4 ng/dl(SD 3.9)。

主要发现

  • 50例(28.6%)出现Gleason分级组进展。
  • 体积法前列腺周围脂肪最高三分位较低三分位进展风险HR 2.63(95%CI 1.23-5.60,p=0.01)。
  • 线性前列腺周围脂肪最高三分位较低三分位进展风险HR 2.30(95%CI 1.01-5.22,p=0.05)。
  • 皮下脂肪测量与进展无关联(p=0.97)。
  • 校正BMI及其他因素后模型结果无实质性改变。

临床怎么用

  • 前列腺MRI测量的前列腺周围脂肪体积或可作为主动监测患者疾病进展风险的辅助评估指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Evidence suggests that visceral fat quantity may be associated with post-prostatectomy outcomes and risk of prostate cancer related death. We evaluated whether increased fat volume, normalized to prostate size, is associated with decreased risk of disease progression. MATERIALS AND METHODS: Patients enrolled on a prospective active surveillance trial for at least 6 months who had magnetic resonance imaging within 2 years of enrollment were eligible. The surveillance protocol included a standardized followup regimen consisting of biennial prostate specific antigen and examination and yearly biopsy. Clinicopathological characteristics were collected at baseline. Three fat measurements were taken using prostate magnetic resonance imaging, including subcutaneous, linear periprostatic (pubic symphysis to prostate) and volumetrically defined periprostatic. Progression was defined as increase in Gleason grade group. Multivariable Cox proportional hazards models were used to evaluate fat volumes normalized by prostate size (stratified into tertiles). RESULTS: A total of 175 patients were included in the study. Average age was 62.5 years (SD 7.4) and average prostate specific antigen was 5.4 ng/dl (SD 3.9). Median followup was 42 months (IQR 18-60) and 50 patients (28.6%) had progression. Compared to the lowest tertile, the highest tertile of volumetric periprostatic fat measurement (HR 2.63, 95% CI 1.23-5.60, p=0.01) and linear periprostatic fat measurement (HR 2.30, 95% CI 1.01-5.22, p=0.05) were associated with worsened progression-free survival, while subcutaneous fat measurement (p=0.97) was not. Importantly, the model did not substantively change when accounting for patient body mass index and other factors. CONCLUSIONS: Increased periprostatic fat volume, normalized to prostate size, may be associated with shortened progression-free survival in men with prostate cancer on active surveillance.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Gregg JR, Surasi DS, Childs A, et al. The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance. J Urol. 2020. PMID: 32718204. doi:10.1097/JU.0000000000001321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。